Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Nearing retirement at 50? Discover wealth management strategies tailored to secure your financial future effectively.
21,324 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Investing in builders requires more than chasing growth. This deep dive unpacks why dream finders homes: promising st...
A stock can crater 97% and still look tempting for income investors. This guide walks you through the due diligence, ...
Bitdeer, the largest bitcoin miner by hashrate, liquidated a significant portion of its BTC holdings this week, drivi...
Investors are eyeing Life Time's Q4 2025 earnings to gauge membership momentum, pricing discipline, and growth strate...
NVIDIA is set to report fiscal Q4 results after the close, with traders betting on a top-line beat and a read on AI d...
Zscaler posted a strong quarter, beating revenue and EPS estimates while signaling durable ARR growth. Here are the n...
AMD’s AI accelerator cycle could change the stock picture if the MI350 ramp and MI450 shipments hit on schedule. This...
A fresh stake from Cross Staff Investments in the Akre Focus ETF could signal a manager’s confidence in Akre’s approa...
Biotech stocks can swing on clinical data and regulatory news. This guide digs into whether crispr therapeutics stock...
A veteran's take on holding (onon) 2025 earnings: what to watch, where margins could move, and how to plan for the Q4...
Harvard Management Company disclosed a strategic reallocation of its crypto portfolio, trimming Bitcoin ETF exposure ...